Making profits working on patients’ expectations, a behavioral analysis of pharmaceutical clinical research

Roberto Ippoliti

Journal of Bioeconomics, 2012, vol. 14, issue 3, 217-241

Abstract: This paper presents a model that demonstrates how pharmaceutical companies can make profits from human experimentation by working on patients’ expectations and physicians’ inability to evaluate innovations in medical knowledge. In order to understand how profits can be made, it is important to analyze the effect the physician’s expectations have on patients, both in the enrolment process and in the collected effectiveness, as well as the nature of the physician’s interest in producing this effect. Starting from the process through which companies collect clinical evidence, the analysis will focus on the economic use of that data on the drug market and the national drug agency’s role. A model illustrates the companies’ potential opportunistic strategies as well as what the public stakeholder’s target should be. Is public intervention really necessary in order to regulate the imperfect market of drugs? In other words, taking imperfection due to the expectation process in human experimentation into account, is there another practicable path? The final normative analysis will try to answer these questions. Copyright Springer Science+Business Media, LLC. 2012

Keywords: Pharmaceutical R&D; Human experimentation; Institutional Review Board; Informed Consent; Drug agency; Medical researcher and research subject; I11 (search for similar items in EconPapers)
Date: 2012
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://hdl.handle.net/10.1007/s10818-011-9121-1 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:kap:jbioec:v:14:y:2012:i:3:p:217-241

Ordering information: This journal article can be ordered from
http://www.springer. ... al/journal/10818/PS2

DOI: 10.1007/s10818-011-9121-1

Access Statistics for this article

Journal of Bioeconomics is currently edited by Ulrich Witt, Michael T. Ghiselin and David Sloan Wilson

More articles in Journal of Bioeconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().